Search - tctmd.com

Displaying 981 - 1000 of 1188

Sort: Relevancy | Date

Presentation

Meta-analysis of Randomized Controlled Trials on the Risk of Bleeding with Dabigatran

Presenter: B.J. Bloom

January 06, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI

L.A. McKeown

January 01, 2014

News Daily News

La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI

L.A. McKeown

January 01, 2014

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

L.A. McKeown

December 30, 2013

Presentation

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Presenter: E. Perdoncin

December 10, 2013

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

Presentation

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Presenter: A. Stazi

December 09, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

EUROMAX: Critical Appraisal and Clinical Implications

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presenter: Sripal Bangalore

October 27, 2013

News Daily News

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

L.A. McKeown

October 04, 2013

News Daily News

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

L.A. McKeown

October 04, 2013

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Jason Kahn

October 04, 2013

News Daily News

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Jason Kahn

October 04, 2013

Presentation

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Presenter: A. Majeed

October 03, 2013

Advertisement

Meta-analysis of Randomized Controlled Trials on the Risk of Bleeding with Dabigatran

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI

La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

EUROMAX: Critical Appraisal and Clinical Implications

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content